Search

The aims of this study included assessment of accuracy of respiratory inductive plethysmography when pulmonary hyperinflation was induced by application of PEEP, and examination of breathing patterns of normal subjects, intubated patients requiring mechanical ventilation and intubated patients immediately before extubation during application of PEEP by demand valve and high gas flow reservoir bag systems. Validation of tidal volume (VT) and end-expiratory level measured with respiratory inductive plethysmography to simultaneous spirometry (SP) was achieved with PEEP levels up to 12.5 cm H2O in 7 normals. In 17 intubated patients, almost all VT values measured with respiratory inductive plethysmography fell within +/- 10% of SP even with 2 to 3 changes of body posture. In normal subjects, increasing levels of PEEP from the demand valve system produced nonprogressive rises of VT and mean inspiratory flow, falls of frequency and fractional inspiratory time (TI/TTOT), and no changes of minute ventilation (Vmin) nor mean expiratory flow. PEEP from the high gas flow reservoir bag system produced nonprogressive rises of VT and rib cage (RC) contribution to VT, and rises of Vmin and mean inspiratory and expiratory flows between 10.0 and 12.5 cm H2O of PEEP. Intubated patients requiring intermittent mandatory ventilation (IMV) had a rapid, shallow breathing pattern unaltered by PEEP levels delivered by either system up to 12.5 cm H2O despite increases of end-expiratory level. Intubated patients who were about to be extubated breathed with patterns closer to ambulatory normal subjects with the exception of their elevated RC contribution to VT.(ABSTRACT TRUNCATED AT 250 WORDS)

We measured the breathing pattern of normal subjects, asymptomatic smokers, asymptomatic and symptomatic asthmatic patients, and patients with chronic obstructive pulmonary disease, restrictive lung disease, primary pulmonary hypertension and anxiety state utilizing respiratory inductive plethysmography. Respiratory rate was increased above the normal in smokers and in patients with COPD, restrictive lung disease and pulmonary hypertension, but remained normal in asthmatic patients. Inspiratory times (TI) of one second or less often occurred in patients with COPD, restrictive lung disease, and pulmonary hypertension. Smokers and patients with symptomatic asthma, COPD, restrictive lung disease and pulmonary hypertension showed heightened respiratory center drive as reflected by elevated mean inspiratory flow (VT/TI). Fractional inspiratory time was reduced to a variable extent in smokers, symptomatic asthmatic patients and patients with COPD, and was a weak indicator of airways obstruction. Patients with COPD often had major fluctuations of expiratory timing, periodic fluctuations of end-expiratory level, and asynchrony between rib cage and abdominal movements. Chronic anxiety was characterized by frequent sighs; episodic rapid rates alternating with apneas were less common. We conclude that analysis of breathing patterns provides diagnostic discrimination among normal subjects and disease states.

Ventilatory monitoring devices that require mouthpiece breathing produce a rise in tidal volume (VT), a fall in frequency (f) and alterations in periodicity and variability of breathing components. Together with the introduction of the respiratory inductive plethysmograph, a reliable noninvasive monitoring device of ventilation, major advances have taken place in understanding the significance of the components of the breathing pattern. We measured the breathing pattern of normal subjects utilizing respiratory inductive plethysmography and continuously processed these data with a microprocessor system. The mean values of the breathing pattern components in normal subjects were not affected by age, but the rhythmicity was more irregular in the elderly. The values of breathing pattern components obtained noninvasively by respiratory inductive plethysmography in normal subjects are fairly predictable in limits similar to other tests of pulmonary function.

We studied the effect of two sequential puffs of metaproterenol (650 μg each puff) delivered with an auxiliary aerosol delivery system on the breathing pattern of patients with symptomatic bronchial asthma who were monitored noninvasively with respiratory inductive plethysmography. Particular attention was directed to respiratory center drive as reflected by mean inspiratory flow and minute ventilation. Both these components were elevated in the eight patients whose mean FEV 1.0 was 1.43 L (45% predicted normal). Two puffs of metaproterenol produced a maximal increase over baseline in FEV 1.0 of 50 ± 25% (SD), whereas no change took place in FEV 1.0 with placebo administration. This dose of metaproterenol did not alter heart rate nor blood pressure throughout the study period of 2 hours. Neither mean inspiratory flow, minute ventilation, nor any component of the breathing pattern changed with this partial reversal of bronchoconstriction. These results suggest that the neural mechanism accounting for heightened respiratory center drive in patients with symptomatic bronchial asthma does not wholly depend on bronchoconstriction.

Recent reports suggest that endogenously released endorphins may exert a modifying influence on respiratory center drive in patients with respiratory disease. In this report, we employed respiratory inductive plethysmography to noninvasively assess breathing patterns with particular attention to respiratory center drive as reflected by mean inspiratory flow. We studied 10 patients with documented chronic obstructive pulmonary disease (6 with hypercapnia and 4 with normocapnia) after treatment with placebo and the opiate antagonist, naloxone. No significant change in breathing pattern was observed in either patient group after treatment with placebo or naloxone, although individual patients displayed greater respiratory drive after naloxone than placebo. Therefore, endorphins do not exert a consistent influence on respiratory center output in patients with chronic obstructive pulmonary disease.

The assumption that the respiratory system behaves with 2 df of motion in healthy persons allows calibration of respiratory inductive plethysmography (RIP) with spirometry (SP). To ascertain whether RIP could be calibrated by the same assumption in patients with lung disease, even though at least 3 df of motion are visualized (ie, upper and lower rib cage and upper and lower abdomen move out of phase), RIP was calibrated by a two-position calibration procedure and validated satisfactorily by simultaneous SP in the erect, semirecumbent, supine, and lateral decubitus positions. In lung disease, the contribution to tidal volume of regions moving independently of the combined rib cage and abdominal movements either is small or remains relatively constant with change of body posture. For clinical monitoring of the resting breathing pattern where patient movements cannot be restricted, respiratory inductive plethysmography can serve as a reliable semiquantitative, noninvasive ventilatory monitoring device.